TEVA

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Cephalon
gptkb:Actavis_Generics
gptkb:Barr_Pharmaceuticals
gptkbp:CEO gptkb:Richard_Francis
gptkbp:country gptkb:Israel
gptkbp:division gptkb:OTC
Generic Medicines
Specialty Medicines
gptkbp:founded 1901
gptkbp:foundedIn gptkb:Jerusalem,_Ottoman_Empire
gptkbp:founder gptkb:Chaim_Salomon
gptkb:Moshe_Levin
gptkb:Yitschak_Elstein
gptkbp:fullName gptkb:Teva_Pharmaceutical_Industries_Ltd.
gptkbp:headquartersLocation gptkb:Petah_Tikva,_Israel
https://www.w3.org/2000/01/rdf-schema#label TEVA
gptkbp:industry Pharmaceuticals
gptkbp:ISIN IL0006290147
gptkbp:keyPerson gptkb:David_Stark
gptkb:Eric_Hughes
gptkb:Eli_Kalif
gptkb:Eric_Drapé
gptkb:Richard_Daniell
gptkb:Sven_Dethlefs
gptkb:Vivek_Joshi
gptkb:Amir_Elstein
gptkb:Richard_Francis
gptkbp:listedOn gptkb:New_York_Stock_Exchange
gptkb:Tel_Aviv_Stock_Exchange
gptkbp:logo Teva Pharmaceutical Industries logo.svg
gptkbp:market Global
gptkbp:netIncome $-2.35 billion (2022)
gptkbp:notableProduct gptkb:Ajovy
gptkb:Austedo
gptkb:Copaxone
gptkbp:numberOfEmployees ~37,000
gptkbp:parentCompany nan
gptkbp:products Over-the-counter drugs
Generic drugs
Specialty medicines
gptkbp:rank One of the largest generic drug manufacturers in the world
gptkbp:revenue $15.8 billion (2022)
gptkbp:servesArea Worldwide
gptkbp:stockExchange gptkb:TASE
gptkb:NYSE
gptkbp:stockSymbol gptkb:TEVA
gptkbp:subsidiary gptkb:Teva_Active_Pharmaceutical_Ingredients
gptkb:Teva_Neuroscience
gptkbp:type gptkb:public_company
gptkbp:website https://www.tevapharm.com/
gptkbp:bfsParent gptkb:Teva_Pharmaceutical_Industries
gptkbp:bfsLayer 5